School of Psychological Sciences, College of Health & Medicine, University of Tasmania, Hobart, TAS, Australia.
National Endometriosis Clinical and Scientific Trials (NECST) Network, UNSW, Sydney, Australia.
Hum Reprod. 2024 May 2;39(5):992-1002. doi: 10.1093/humrep/deae063.
What is the relationship between sexual function, health-related quality of life (HRQoL), and laparoscopic surgery in individuals living with endometriosis?
A higher number of laparoscopic surgeries is significantly associated with poorer HRQoL and greater levels of sexual dysfunction in individuals with endometriosis.
Prior research indicates that endometriosis is associated with lowered HRQoL and sexual function and that these outcomes are influenced by endometriosis-related symptom profiles, medical, and surgical management. A limited number of studies have examined changes in sexual function in individuals with endometriosis following laparoscopic surgery or following repeated surgeries.
STUDY DESIGN, SIZE, DURATION: A cross-sectional community-based online survey was used to examine the relationships between sexual function, HRQoL, and laparoscopic surgery (n = 210).
PARTICIPANTS/MATERIALS, SETTING, METHODS: Individuals with a self-reported diagnosis of endometriosis were recruited via online advertising through social media and gynaecology clinics. Endometriosis-specific data (e.g. diagnostic delay, symptom experience) was collected in addition to engagement with laparoscopic surgery, level of HRQoL (EuroQol-5 Dimension: EQ-5D-5L), and sexual function (Female Sexual Function Index: FSFI). Bivariate correlational analyses and hierarchical multiple regression were used to determine the associations between the variables of interest.
Individuals with endometriosis have substantially poorer HRQoL in comparison to Australian normative samples, with greater levels of endometriosis-related symptom burden, distress, and pain significantly associated with lower levels of HRQoL. The mean FSFI score was suggestive of clinically significant female sexual dysfunction, with the lowest level of function noted in the domain of sexual pain and the highest level of function noted in the sexual satisfaction domain. A greater number of laparoscopic surgeries was significantly associated with poorer overall HRQoL and greater levels of sexual dysfunction.
LIMITATIONS, REASONS FOR CAUTION: The cross-sectional nature of the data precludes direct findings of causality and further longitudinal research is recommended. The information pertaining to engagement in laparoscopic surgery was self-report in nature and was not medically verified.
The study's findings highlight the pervasive impact of endometriosis on all domains of living, emphasizing the need to extend treatment planning beyond that of physical pain management alone. Early referral for assessment and management of sexual wellbeing is recommended prior to, and post-surgical intervention, with a focus on maintaining post-surgical changes, potentially reducing the need for multiple surgeries.
STUDY FUNDING, COMPETING INTEREST(S): The study was not associated with research funding. Author CN reports grant funding from the Australian Government and Medical Research Future Fund (MRFF) and was a previous employee of CSL Vifor (formerly Vifor Pharma Pty Ltd).
N/A.
在患有子宫内膜异位症的个体中,性功能、与健康相关的生活质量(HRQoL)和腹腔镜手术之间存在什么关系?
进行更多次的腹腔镜手术与 HRQoL 较差和性功能障碍程度更高显著相关。
先前的研究表明,子宫内膜异位症与 HRQoL 降低和性功能障碍有关,这些结果受子宫内膜异位症相关症状谱、医疗和手术管理的影响。少数研究检查了接受腹腔镜手术后或多次手术后子宫内膜异位症患者性功能的变化。
研究设计、规模、持续时间:使用横断面社区为基础的在线调查来研究性功能、HRQoL 和腹腔镜手术之间的关系(n=210)。
参与者/材料、设置、方法:通过社交媒体和妇科诊所的在线广告招募自我报告诊断为子宫内膜异位症的个体。除了腹腔镜手术的参与度、HRQoL(欧洲五维健康量表:EQ-5D-5L)和性功能(女性性功能指数:FSFI)外,还收集了子宫内膜异位症特异性数据(例如诊断延迟、症状体验)。使用双变量相关分析和分层多元回归来确定感兴趣变量之间的关联。
与澳大利亚参考样本相比,患有子宫内膜异位症的个体的 HRQoL 明显较差,与子宫内膜异位症相关的症状负担、痛苦和疼痛程度较高与较低的 HRQoL 水平显著相关。FSFI 评分的平均值提示存在临床显著的女性性功能障碍,在性功能疼痛域中记录到最低水平的功能,在性满足域中记录到最高水平的功能。进行更多次的腹腔镜手术与整体 HRQoL 较差和性功能障碍程度较高显著相关。
局限性、谨慎的原因:数据的横断面性质排除了直接因果关系的发现,建议进一步进行纵向研究。腹腔镜手术参与的信息是自我报告的,未经医学核实。
该研究的结果强调了子宫内膜异位症对所有生活领域的普遍影响,强调需要将治疗计划扩展到不仅仅是身体疼痛管理。建议在手术干预之前和之后,提前转诊评估和管理性功能健康,重点是维持手术后的变化,可能减少多次手术的需要。
研究资金、竞争利益:该研究与研究资金无关。作者 CN 报告从澳大利亚政府和医学研究未来基金(MRFF)获得资助,并且曾是 CSL Vifor(前身为 Vifor Pharma Pty Ltd)的员工。
无。